Clinical Trial Update: Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Rituximab plus CHOP chemotherapy for diffuse large B-cell lymphoma (DLBCL), including people with HIV, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• HIV Infection

Drugs mentioned

• CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
• Rituximab (rituximab)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Diffuse Large B-cell Lymphoma, HIV | Phase 2 | Status: COMPLETED